SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Discuss it all with Malko... while u wait.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Malko who wrote (183)12/11/1998 4:37:00 PM
From: Bill on the Hill  Read Replies (1) of 277
 
ASTM closed up 1/4 today and will be featured in lots of Sunday editions of newspapers over the weekend. The technology has met with pre-approval for Europe and they have advance orders for 30,000 of the blood kits at a cost of 10 - 15k each when FDA gives approval for the USA market. The scientists who have created the procedure at Duke Univ. have stated that with a supply of 200,000 umbilical donors we would have a pool (pardon me) of blood source which would be able to supply stem cell blood for anyone in the US that would need it.

Religious organizations should not have any problem with this technology as it does not come from aborted fetus but from umbilical cords which are harvested at the time of birth. A portion of the umbilical cord can be stored for the birth person in case of future illness to generate new cells. I heard today of a possible link to this technology and a cure for Sickle Cell Anemia.

This is a major scientific breakthrough and the stock is very inexpensive at these prices. The company will be in the market with their technology soon and are already marketing one of their Bio products. This will be profitable very very soon.

I will hold my shares for a minimum price of $15.00

Bill

ASTM ask 3 1/4 bid 3 5/16
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext